Bitterness is often dismissed as a nuisance of the dinner plate, the flavor note that makes children push away Brussels sprouts and coffee drinkers reach for sugar. Yet for evolutionary biologists and physiologists, the ability to detect bitter compounds is one of humanity’s most important chemical defense systems, a sensory alarm that has protected our species from ingesting poisons for millions of years. The molecular hardware behind this alarm consists of a family of roughly 25 G protein-coupled receptors known as taste 2 receptors, or TAS2Rs, which together can recognize hundreds of chemically diverse bitter substances ranging from plant alkaloids to synthetic drugs. Over the past two decades, researchers around the world have systematically matched these receptors to their activating compounds, a process known as de-orphanization. That effort has been remarkably successful: 22 of the 26 human TAS2Rs considered functional have now been linked to at least one bitter agonist, and some receptors respond to dozens of different molecules.
But a stubborn handful of receptors has resisted every attempt at de-orphanization. TAS2R19, TAS2R42, TAS2R45, and TAS2R60 remain orphans, receptors with no known activating compounds, and their biological roles have therefore remained shrouded in uncertainty. At the same time, even among receptors classified as functional, genetic variation has produced variants labeled nonfunctional, sometimes on the basis of just one or a few amino acid substitutions. Two famous examples are TAS2R9 and TAS2R38. In TAS2R9, an alanine at position 187 yields a functional receptor, while a valine at the same position renders it unresponsive to known agonists such as the antibiotic ofloxacin. TAS2R38 is even more celebrated: its PAV variant makes people exquisitely sensitive to the bitter compounds phenylthiocarbamide and propylthiouracil, whereas the AVI variant is classed as nonfunctional and defines the classic taster-non-taster divide in human populations. Whether such variants are truly dead or have simply shifted their ligand preferences to unknown chemicals has been impossible to determine from sequence alone.
A new study by Praveen Kumar and Maik Behrens, published in Current Research in Food Science, tackles this puzzle from an unexpected angle. Instead of hunting for missing agonists, the researchers asked a more fundamental question: do these orphan and supposedly nonfunctional receptors even reach the cell surface, the location where a receptor must reside to detect compounds outside the cell? A receptor that fails to fold properly, or that gets stuck in the endoplasmic reticulum during biosynthesis, can never respond to any ligand, no matter how thorough the screening. Conversely, a receptor that traffics efficiently to the plasma membrane is structurally intact and remains a plausible candidate for future ligand discovery. The answer to this question provides a powerful clue about functionality that does not require knowing a single agonist.
To measure cell surface localization, the team employed a clever tagging strategy developed recently in their laboratory. Each receptor was engineered to carry an 11-amino-acid HiBiT sequence, a small peptide tag appended to the amino-terminal end of an sst3 export tag derived from the rat somatostatin receptor subtype 3, which is itself crucial for routing receptors to the plasma membrane. The HiBiT tag binds with high affinity to a complementary protein fragment called LgBiT, and together the two fragments generate luminescence. Because some of the commercial detection reagents are membrane-impermeable, they can only reach HiBiT tags exposed on the outside of living cells, allowing researchers to quantify exactly how much of each receptor sits at the cell surface. A second, lytic detection reagent breaks the cells open and reveals the total receptor population, permitting calculation of the fraction that successfully completed trafficking. The entire workflow runs on a fluorometric imaging plate reader, making it suitable for high-throughput analysis.
The first test cases were the taster and non-taster variants of TAS2R9 and TAS2R38. Functional assays in HEK293T-Gα16gust44 cells confirmed the expected behavior: the TAS2R38-PAV variant responded to propylthiouracil and the TAS2R9-187A variant responded to ofloxacin, while their non-taster counterparts remained silent. Importantly, adding the HiBiT tag did not abolish function, although the tagged TAS2R38 showed a slightly reduced response, a caveat the authors note openly. When the researchers then measured cell surface abundance using the luminescence assay, both functional and nonfunctional variants proved to be present at the plasma membrane. The non-taster TAS2R38-AVI variant reached the cell surface at a reduced fraction, about 6 percent of its total pool compared with 17 percent for the PAV variant, and the TAS2R9-187V variant showed only a modest reduction relative to its functional partner. Immunocytochemical staining of living, non-permeabilized cells with an anti-HiBiT antibody independently confirmed these surface-localization patterns.
These results carry significant implications for how scientists interpret receptor polymorphisms. For TAS2R9-187V, the data suggest that no gross defect in folding or routing explains its apparent nonfunctionality. Position 187 sits in the upper part of the fifth transmembrane domain, a region that could plausibly contribute to agonist binding. The authors therefore propose that rather than being a lost receptor, this variant may simply respond to a different, perhaps smaller, agonist that has not yet been tested. The bulkier valine residue could sterically reshape the ligand-binding pocket or restrict the conformational movements of the transmembrane helices needed for receptor activation. Similarly, for TAS2R38-AVI, the demonstration of structural integrity at the cell surface supports earlier speculation that this variant may have evolved altered ligand specificity, possibly responding to unknown compounds in the pulp of the Antidesma bunius fruit, which produces a peculiar bitter taste in individuals carrying the AVI haplotype.
The four orphan receptors yielded equally revealing results. All four could be detected at the cell surface by luminescence assays, but their trafficking efficiencies differed dramatically. TAS2R19 stood out as the star performer: 83 percent of its total receptor pool reached the plasma membrane, a proportion exceeding even that of TAS2R14, the human bitter receptor with the largest number of known agonists. TAS2R60 was by far the most abundantly produced receptor subtype, and although only 9 percent of it reached the surface, the absolute quantity there surpassed all TAS2Rs except TAS2R19. In sharp contrast, TAS2R42 and TAS2R45 showed negligible surface signals in immunocytochemical staining, with cell surface fractions of just 3 and 6 percent respectively. TAS2R42 is synthesized reasonably well but trafficked poorly, suggesting retention in the endoplasmic reticulum, while TAS2R45 appears to be produced at very low levels overall, raising the possibility that it may functionally represent an expressed pseudogene.
The contrasting profiles of the four orphans allow the authors to draw nuanced conclusions about why these receptors have resisted de-orphanization. For TAS2R19 and TAS2R60, biosynthesis and cell surface routing in heterologous cells clearly do not explain the absence of known agonists. Both receptors are closely related to already de-orphaned receptors in mice: the mouse receptor Tas2r135, an ortholog of TAS2R60, has 11 identified bitter agonists, and TAS2R19 is highly homologous to TAS2R20, which has 10 known agonists. Problems with coupling to the calcium signaling cascade used in the assay system also seem unlikely, given that far more distantly related receptors, including one from cartilaginous fish, have been successfully screened in the same cellular platform. The most probable explanation for these two receptors is simply that the right bitter compounds have not yet been tested, pointing toward unexplored chemical territory.
That territory, the authors argue, is vast and seriously under-sampled. Most bitter agonist discovery has focused on synthetic compounds and molecules from flowering plants, while bitter substances from animals, mushrooms and other fungi, prokaryotic organisms, and plants belonging to older lineages of the plant kingdom have barely been investigated. Recent work identifying bitter compounds from mushrooms, such as those isolated from the bracket fungus Amaropostia stiptica, illustrates the kind of neglected sources that could harbor activators for the remaining orphans. Closing this knowledge gap, the study suggests, will require intensified bioprospecting efforts guided by the growing recognition that bitter taste receptors do far more than guard the tongue. They are expressed in the gut, airways, and other tissues, where they influence hormone secretion, glucose homeostasis, and possibly innate defense, making every de-orphanized receptor a potential target for nutrition and medicine.
The HiBiT-based localization assay itself may prove to be the study’s most lasting contribution. By providing a rapid, quantitative, high-throughput readout of receptor biosynthetic integrity that requires no knowledge of agonists, the method offers a rational triage tool for the bitter taste receptor field. Receptors that traffic well, like TAS2R19 and TAS2R60, become priority targets for expanded ligand screening, while those with severe trafficking defects, like TAS2R42 and TAS2R45, may need engineered chaperones, modified expression systems, or tissue-specific organoid models to reveal their secrets. As the authors note, genetically engineered organoids derived from taste tissue or the intestine could eventually provide more natural cellular environments for such studies, overcoming limitations of immortalized cell lines that express numerous receptors endogenously. For now, the message is clear: four orphan receptors and two supposedly dead receptor variants are very much alive at the cell surface, waiting for the right molecule to wake them.
Subject of Research: Cell surface localization of orphan and nonfunctional human bitter taste receptors
Article Title: Cell surface localization of receptors considered nonfunctional and orphan bitter taste receptors
Article References: Kumar, P., & Behrens, M. (2026). Cell surface localization of receptors considered nonfunctional and orphan bitter taste receptors. Current Research in Food Science, 13, Article 101551. https://doi.org/10.1016/j.crfs.2026.101551
Image Credits: AI Generated
DOI: 10.1016/j.crfs.2026.101551
Keywords: bitter taste receptors, TAS2R, orphan receptors, HiBiT tag, cell surface localization, G protein-coupled receptors, TAS2R38, TAS2R9, de-orphanization, taste perception, receptor trafficking, food science
Cite Scienmag News
APA MLA Chicago
Alan Morgan. (September 12, 2026). Orphan Bitter Taste Receptors Found on Cell Surfaces, Hinting at Hidden Functions. Scienmag. https://scienmag.com/orphan-bitter-taste-receptors-found-on-cell-surfaces-hinting-at-hidden-functions/
Alan Morgan. “Orphan Bitter Taste Receptors Found on Cell Surfaces, Hinting at Hidden Functions.” Scienmag, 12 September 2026, https://scienmag.com/orphan-bitter-taste-receptors-found-on-cell-surfaces-hinting-at-hidden-functions/. Accessed 12 September 2026.
Alan Morgan. “Orphan Bitter Taste Receptors Found on Cell Surfaces, Hinting at Hidden Functions.” Scienmag. September 12, 2026. https://scienmag.com/orphan-bitter-taste-receptors-found-on-cell-surfaces-hinting-at-hidden-functions/
Copy citation Download RIS
Tags: bitter taste receptor functionsbitter taste receptorscell surface localizationcell surface receptors in sensory perceptionchemical defense mechanismsde-orphanizationevolutionary role of bitter tastefood scienceG protein-coupled receptorsG protein-coupled receptors in tasteHiBiT taghidden functions of taste receptorshuman taste receptor diversityimplications for taste biology and physiologyorphan receptorsreceptor activation and ligand discoveryreceptor traffickingrole of bitter receptors beyond tasteTAS2RTAS2R de-orphanization researchTAS2R orphan receptorsTAS2R38TAS2R9taste perception
